A high-affinity mAb targeting the coagulation factors domain of NRP-1 (anti-NRP-1B) has been shown to inhibit VEGF-A-induced migration of human endothelial cells and tumor formation in animal models avoiding VEGF-A-binding to NRP-1 (66–69). The gene discussed is VEGFA; the disease is neoplasm.